Back to Search
Start Over
Enrollment Passes Halfway Milestone in Clinical Trial Evaluating the Effect of an Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born with Single Ventricle Congenital Heart Defects
- Source :
- PR Newswire. August 9, 2018
- Publication Year :
- 2018
-
Abstract
- DUARTE, Calif., Aug. 9, 2018 /PRNewswire/ -- Prolacta Bioscience, the pioneer in human milk-based neonatal nutritional products for premature infants, announced today that enrollment has passed the halfway milestone in [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.549482566